Protean eGov Technologies Statistics

Total Valuation

NSE:PROTEAN has a market cap or net worth of INR 38.52 billion. The enterprise value is 36.21 billion.

Market Cap	38.52B
Enterprise Value	36.21B

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	40.55M
Shares Outstanding	n/a
Shares Change (YoY)	+0.45%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	31.27M

Valuation Ratios

The trailing PE ratio is 41.66 and the forward PE ratio is 33.97.

PE Ratio	41.66
Forward PE	33.97
PS Ratio	4.58
PB Ratio	3.86
P/TBV Ratio	4.05
P/FCF Ratio	21.44
P/OCF Ratio	19.99
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.03, with an EV/FCF ratio of 20.16.

EV / Earnings	39.16
EV / Sales	4.31
EV / EBITDA	45.03
EV / EBIT	68.85
EV / FCF	20.16

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.07.

Current Ratio	2.08
Quick Ratio	1.96
Debt / Equity	0.07
Debt / EBITDA	0.85
Debt / FCF	0.38
Interest Coverage	22.47

Financial Efficiency

Return on equity (ROE) is 9.61% and return on invested capital (ROIC) is 3.26%.

Return on Equity (ROE)	9.61%
Return on Assets (ROA)	2.64%
Return on Invested Capital (ROIC)	3.26%
Return on Capital Employed (ROCE)	4.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	713
Asset Turnover	0.67
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.57%
50-Day Moving Average	1,269.06
200-Day Moving Average	1,650.81
Relative Strength Index (RSI)	28.99
Average Volume (20 Days)	225,573

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:PROTEAN had revenue of INR 8.41 billion and earned 924.60 million in profits. Earnings per share was 22.65.

Revenue	8.41B
Gross Profit	1.95B
Operating Income	525.90M
Pretax Income	1.18B
Net Income	924.60M
EBITDA	804.10M
EBIT	525.90M
Earnings Per Share (EPS)	22.65

Full Income Statement

Balance Sheet

The company has 3.00 billion in cash and 685.30 million in debt, giving a net cash position of 2.31 billion.

Cash & Cash Equivalents	3.00B
Total Debt	685.30M
Net Cash	2.31B
Net Cash Per Share	n/a
Equity (Book Value)	9.99B
Book Value Per Share	246.76
Working Capital	2.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.93 billion and capital expenditures -130.60 million, giving a free cash flow of 1.80 billion.

Operating Cash Flow	1.93B
Capital Expenditures	-130.60M
Free Cash Flow	1.80B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 23.18%, with operating and profit margins of 6.26% and 11.00%.

Gross Margin	23.18%
Operating Margin	6.26%
Pretax Margin	14.09%
Profit Margin	11.00%
EBITDA Margin	9.56%
EBIT Margin	6.26%
FCF Margin	21.37%

Dividends & Yields

NSE:PROTEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	43.76%
Buyback Yield	-0.45%
Shareholder Yield	n/a
Earnings Yield	2.40%
FCF Yield	4.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a